The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Trimme, don’t take this the wrong way but could you stop posting pointless excrement. Last week you were incessantly telling the board this was a bum buy, it’s going nowhere et etc. Now (and presumably because you got the entry point you were after) you’ve become a turncoat and are telling all (including the LTH’s) how the market works, and acting like the Sareum master. Personally turncoat equals turd head in my book.
I don't see how one could possibly take that the wrong way Bobbler!
Catch more bee’s with honey and all that :-)
Some c...wombles like to piggyback when money is to be made but forget their own history, such is the disease within.
Really Trimme: as an example:
RE: Share Price18 Jun 2021 12:13
Grow up and read my post properly, I am already in this to my disappointment
Em…..knob jockey and liar?
If after 26 years of investing you haven't paid off your mortgage you are either:
a) intellectually challenged
b) not good at investing
c) a liar
d) all of the above
Maf Some people have lost their house after 26 years of investing!
No not investing girl ... Day trading and gambling ... there is a difference
You said investing though
Yet again Trimme for some unknown reason you are making contradictory remarks.
Everyone knows about potential which is why we invest in who we do. I am in BRH because of its potential just like you are but it has potential. I am down two thirds in that but still believe in its potential.
You don't know what will happen with any share, nobody does like nobody does about any share it is all potential until it happens.
This has huge potential because of what it has been working on for over a decade which is hopefully about to come to fruition. Then we can buy a meal out of the rewards we receive for investing in that potential.
eh, can't get more tangible than investment to the tune of £2m+ within 2 weeks in potential-
Significant clear opportunities available to Sareum
• No marketed products with selectivity for TYK2 – important for differentiation
• Oral twice-daily dosing in mice, potential for once-daily dosing in humans
• Favourable selectivity profile vs JAK2 and JAK3 kinases (cf tofacitinib, baricitinib)
• Encouraging results with SDC-1801 in initial cellular studies co-funded by UKRI
• SDC-1801 reduces the levels of cytokines associated with ARDS in human lung cells infected with SARs-CoV-2
• Experimental phases to complete by end of June and data analysis to complete shortly thereafter.
Validation and evidence-
Pairo-Castineira et al. Nature 2021 591, 92–98
Huang et al Lancet 2020; 395:497-506
Berg et al Eur Respir J 2017; 50:1601953
Eli Lilly & Co press release 14 Sept 2020
Dr Parker put in his chairman's statement in the half yearly RNS (all needs to be signed off by advisors etc)-
'SDC-1801 does indeed downregulate the increase in cytokines believed to be responsible for ARDS and the cytokine storm following infection with SARS-CoV-2'.
As per the £1,470,000 investment RNS from Dr Mitchell-
"These new funds will also help us to further explore the potential benefit of SDC-1801 against Covid-19 and progress the preclinical development of our second TYK2/JAK1 inhibitor SDC-1802 against cancers".
Hawkes ... at the expense of being called "corky the cat" or did you mean "****y"? .. I first got in to this share at sub 1p levels so I am comfortable at these levels. Most of my other investments have also done quite well. One or 2 of them show a paper loss at the moment but they will recover. If I lost the lot of course I would not be a happy camper but my pension and house are secured outside my ISA and trading accounts. There is no risk of me losing my house ... hence my comments ... One BIG difference is I invest based on data and I don't speculate or look for a fast buck ... Sure no one can guarantee returns but you can mitigate risks by RESEARCHING and not pumping and dumping ... that's for MMs, day traders and boy racers.... I'm sorry if some have made a loss as wish everyone success with their Investments .... whatever their strategy .... but if you hold instead of day trading you will score in the long run ... Love and kisses Mafuta